[
  {
    "_id": "ABSI",
    "defaultKeyStatistics": {
      "maxAge": 1,
      "priceHint": 4,
      "enterpriseValue": 337641440,
      "forwardPE": -5.8169017,
      "profitMargins": 0,
      "floatShares": 85092303,
      "sharesOutstanding": 113556000,
      "sharesShort": 13343673,
      "sharesShortPriorMonth": 12082837,
      "sharesShortPreviousMonthDate": "2024-08-29T20:00:00.000Z",
      "dateShortInterest": "2024-09-29T20:00:00.000Z",
      "sharesPercentSharesOut": 0.1175,
      "heldPercentInsiders": 0.20318002,
      "heldPercentInstitutions": 0.6101,
      "shortRatio": 14.49,
      "shortPercentOfFloat": 0.1741,
      "beta": 2.196,
      "impliedSharesOutstanding": 113556000,
      "category": null,
      "bookValue": 1.952,
      "priceToBook": 2.1157787,
      "fundFamily": null,
      "legalType": null,
      "lastFiscalYearEnd": "2023-12-30T19:00:00.000Z",
      "nextFiscalYearEnd": "2024-12-30T19:00:00.000Z",
      "mostRecentQuarter": "2024-06-29T20:00:00.000Z",
      "netIncomeToCommon": -92264000,
      "trailingEps": -0.93,
      "forwardEps": -0.71,
      "pegRatio": -0.2,
      "lastSplitFactor": null,
      "enterpriseToRevenue": 103.89,
      "enterpriseToEbitda": -4.021,
      "52WeekChange": 1.9701493,
      "SandP52WeekChange": 0.3593408
    },
    "summaryProfile": {
      "address1": "18105 SE Mill Plain Boulevard",
      "city": "Vancouver",
      "state": "WA",
      "zip": "98683",
      "country": "United States",
      "phone": "360 949 1041",
      "website": "https://www.absci.com",
      "industry": "Biotechnology",
      "industryKey": "biotechnology",
      "industryDisp": "Biotechnology",
      "sector": "Healthcare",
      "sectorKey": "healthcare",
      "sectorDisp": "Healthcare",
      "longBusinessSummary": "Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; and with AstraZeneca PLC for AI-driven drug discovery against an oncology target. The company was founded in 2011 and is headquartered in Vancouver, Washington.",
      "fullTimeEmployees": 155,
      "companyOfficers": [],
      "maxAge": 86400
    },
    "price": {
      "maxAge": 1,
      "preMarketChangePercent": 0.0150754,
      "preMarketChange": 0.0599999,
      "preMarketTime": "2024-10-16T09:26:45.000Z",
      "preMarketPrice": 4.04,
      "preMarketSource": "FREE_REALTIME",
      "postMarketChangePercent": 0.0169491,
      "postMarketChange": 0.0699997,
      "postMarketTime": "2024-10-16T19:19:01.000Z",
      "postMarketPrice": 4.2,
      "postMarketSource": "FREE_REALTIME",
      "regularMarketChangePercent": 0.037688468,
      "regularMarketChange": 0.1500001,
      "regularMarketTime": "2024-10-16T16:00:01.000Z",
      "priceHint": 4,
      "regularMarketPrice": 4.13,
      "regularMarketDayHigh": 4.24,
      "regularMarketDayLow": 3.99,
      "regularMarketVolume": 743632,
      "averageDailyVolume10Day": 695710,
      "averageDailyVolume3Month": 926676,
      "regularMarketPreviousClose": 3.98,
      "regularMarketSource": "FREE_REALTIME",
      "regularMarketOpen": 4,
      "exchange": "NMS",
      "exchangeName": "NasdaqGS",
      "exchangeDataDelayedBy": 0,
      "marketState": "POSTPOST",
      "quoteType": "EQUITY",
      "symbol": "ABSI",
      "underlyingSymbol": null,
      "shortName": "Absci Corporation",
      "longName": "Absci Corporation",
      "currency": "USD",
      "quoteSourceName": "Nasdaq Real Time Price",
      "currencySymbol": "$",
      "fromCurrency": null,
      "toCurrency": null,
      "lastMarket": null,
      "marketCap": 468986304
    },
    "financialData": {
      "maxAge": 86400,
      "currentPrice": 4.13,
      "targetHighPrice": 13,
      "targetLowPrice": 6,
      "targetMeanPrice": 8.29,
      "targetMedianPrice": 7,
      "recommendationMean": 2,
      "recommendationKey": "buy",
      "numberOfAnalystOpinions": 7,
      "totalCash": 145246000,
      "totalCashPerShare": 1.279,
      "ebitda": -83964000,
      "totalDebt": 13332000,
      "quickRatio": 5.705,
      "currentRatio": 6.486,
      "totalRevenue": 3250000,
      "debtToEquity": 6.019,
      "revenuePerShare": 0.033,
      "returnOnAssets": -0.23976,
      "returnOnEquity": -0.42237,
      "freeCashflow": -28843000,
      "operatingCashflow": -59989000,
      "revenueGrowth": -0.623,
      "grossMargins": 0,
      "ebitdaMargins": 0,
      "operatingMargins": -21.040161,
      "profitMargins": 0,
      "financialCurrency": "USD"
    },
    "lastModified": "2024-10-15T02:04:20.577Z"
  }
]
